Elena V Mishina
Overview
Explore the profile of Elena V Mishina including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Christensen C, Chang J, Rostron B, Hammad H, van Bemmel D, Del Valle-Pinero A, et al.
Cancer Epidemiol Biomarkers Prev
. 2025 Jan;
34(1):207.
PMID: 39780619
No abstract available.
2.
Agyeman A, Bandukwala A, Bouri K, Hawes J, Krainak D, Lababidi S, et al.
Biomark Med
. 2023 Sep;
17(11):523-531.
PMID: 37713233
The US FDA convened a virtual public workshop with the goals of obtaining feedback on the terminology needed for effective communication of multicomponent biomarkers and discussing the diverse use of...
3.
Hoag S, Mishina E, Viray L, Wang F, Hollenbeck G, Koszowski B, et al.
Pharm Dev Technol
. 2022 Jul;
27(6):646-653.
PMID: 35850567
The rate of nicotine absorption from tobacco products is a determinant of addiction potential and other detrimental health effects. Oral nicotine bioavailability from moist snuff smokeless tobacco (ST) is influenced...
4.
Hiler M, Weidner A, Hull L, Kurti A, Mishina E
Tob Control
. 2021 Nov;
32(4):480-488.
PMID: 34732539
Objective: This scoping review provides an overview of the existing literature on biomarkers of exposure from electronic nicotine delivery systems (ENDS) use and identifies gaps in existing knowledge. Data Sources:...
5.
Christensen C, Chang J, Rostron B, Hammad H, van Bemmel D, Del Valle-Pinero A, et al.
Cancer Epidemiol Biomarkers Prev
. 2021 Jul;
30(10):1947-1955.
PMID: 34289969
Background: Former smokers who currently use e-cigarettes have lower concentrations of biomarkers of tobacco toxicant exposure than current smokers. It is unclear whether tobacco toxicant exposure reductions may lead to...
6.
7.
Chang C, Cheng Y, Cho T, Mishina E, Del Valle-Pinero A, van Bemmel D, et al.
Nicotine Tob Res
. 2017 Dec;
21(1):3-13.
PMID: 29253243
Introduction: Since 2009, the United States (US) Food and Drug Administration (FDA) Center for Tobacco Products (CTP) has had the authority to regulate the manufacture, distribution, and marketing of tobacco...
8.
Mishina E, Hoffman A
Nicotine Tob Res
. 2013 Nov;
16(3):253-62.
PMID: 24253379
Introduction: Dissolvable tobacco products (DTPs) are relatively new to the market. Some researchers and manufacturers describe them as finely ground tobacco that has been compressed into sticks, strips, and orbs...